Mountain Valley MD Holdings Inc

OTCQB:MVMDF USA Drug Manufacturers - Specialty & Generic
Market Cap
$7.05 Million
Market Cap Rank
#31164 Global
#10255 in USA
Share Price
$0.02
Change (1 day)
+0.00%
52-Week Range
$0.02 - $0.02
All Time High
$1.74
About

Mountain Valley MD Holdings Inc., a biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol solubility enhances solubility for previously insol… Read more

Mountain Valley MD Holdings Inc (MVMDF) - Total Assets

Latest total assets as of September 2025: $1.39 Million USD

Based on the latest financial reports, Mountain Valley MD Holdings Inc (MVMDF) holds total assets worth $1.39 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Mountain Valley MD Holdings Inc - Total Assets Trend (2020–2025)

This chart illustrates how Mountain Valley MD Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Mountain Valley MD Holdings Inc - Asset Composition Analysis

Current Asset Composition (March 2025)

Mountain Valley MD Holdings Inc's total assets of $1.39 Million consist of 70.5% current assets and 29.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 62.8%
Accounts Receivable $0.00 0.0%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $100.00K 3.7%
Goodwill $0.00 0.0%

Asset Composition Trend (2020–2025)

This chart illustrates how Mountain Valley MD Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Mountain Valley MD Holdings Inc's current assets represent 70.5% of total assets in 2025, an increase from 19.3% in 2020.
  • Cash Position: Cash and equivalents constituted 62.8% of total assets in 2025, up from 14.2% in 2020.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 43.0% in 2020.
  • Asset Diversification: The largest asset category is intangible assets at 3.7% of total assets.

Mountain Valley MD Holdings Inc Competitors by Total Assets

Key competitors of Mountain Valley MD Holdings Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Mountain Valley MD Holdings Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.02

Lower asset utilization - Mountain Valley MD Holdings Inc generates 0.02x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -272.40% - -25.76%

Negative ROA - Mountain Valley MD Holdings Inc is currently not profitable relative to its asset base.

Mountain Valley MD Holdings Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 7.83 27.82 15.34
Quick Ratio 7.83 19.87 15.34
Cash Ratio 0.00 0.00 0.00
Working Capital $553.00K $ 6.44 Million $ 5.94 Million

Mountain Valley MD Holdings Inc - Advanced Valuation Insights

This section examines the relationship between Mountain Valley MD Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.32
Latest Market Cap to Assets Ratio 1.88
Asset Growth Rate (YoY) -69.4%
Total Assets $2.74 Million
Market Capitalization $5.14 Million USD

Valuation Analysis

Above Book Valuation: The market values Mountain Valley MD Holdings Inc's assets above their book value (1.88 x), reflecting positive investor sentiment about the company's future prospects.

Significant Asset Reduction: Mountain Valley MD Holdings Inc's assets decreased by 69.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Mountain Valley MD Holdings Inc (2020–2025)

The table below shows the annual total assets of Mountain Valley MD Holdings Inc from 2020 to 2025.

Year Total Assets Change
2025-03-31 $2.74 Million -69.41%
2024-03-31 $8.97 Million -46.53%
2023-03-31 $16.77 Million -33.64%
2022-03-31 $25.27 Million -20.05%
2021-03-31 $31.61 Million +158.37%
2020-03-31 $12.23 Million --